preloader image of the website

Why Invest

As per report:

The number of Assisted Reproductive Technology (ART) cycles performed by U.S. fertility clinics has risen strongly since 2014 and is estimated to total a record 333,600 IVF procedures in 2018, with demand still growing from the ranks of 7+ million infertile American women.

However, the high price of IVF cycles ($12,400 each cycle, sometimes requiring multiple cycles), plus fertility drugs, exams, and diagnostic tests, deters many. The total price tag can top $50,000 or more. And fertility clinics tend to be located in large metro areas, so accessibility is an issue for rural patients. Only 15 states mandate insurance coverage, so most pay out-of-pocket.

In another report by global market insights:

In-vitro Fertilization Services Market size was valued at USD 10.7 billion in 2018 and is expected to witness more than 7% CAGR from 2019 to 2025.

Investors see big money in infertility. And they’re transforming the industry

Top 6 Things to Know About the U.S. Fertility Clinics Industry

In-vitro Fertilization Services Market Size By Procedure

For more information about an investment opportunity with RBC
Please contact us at (847) 578-8485 or [email protected].

References: BB Biotech, Investing News/Life Science, American Clinical Laboratory Association, U.S. Food & Drug Administration, PR Newswire[1], PR Newswire[2], Journal of Clinical Microbiology, The Journal of Applied Laboratory Medicine, Investing News: Everything You Need to Know about Biotech